Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Shenzhen Stock Exchange 002603.SZ
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -31.07 M
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities is USD -31.07 M for the year ending December 31, 2023, a 66.34% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
-
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -92.31 M, a -94.12% change year over year.
-
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -47.55 M, a -1,234.41% change year over year.
-
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD -3.56 M, a 85.37% change year over year.
-
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -24.35 M, a -16.43% change year over year.
Key data
| Date | Net Cash Used Provided By Financing Activities | Dividends Paid | Capital Expenditure | Effect Of Forex Changes On Cash |
|---|
Market news
Loading...
Shenzhen Stock Exchange: 002603.SZ
| CEO | Mr. Xiang Jun Wu |
| IPO Date | July 28, 2011 |
| Location | China |
| Headquarters | No. 238 Tianshan Street |
| Employees | 13,958 |
| Sector | Health Care |
| Industries | |
Description
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others. The company sells its products through physical display and online. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email